Request for Draft Assessment Reports of Aminopyralid and Mandipropamid
Dear European Food Safety Authority,
Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:
Draft Assessment Reports of Aminopyralid and Mandipropamid
Thank you in advance.
Yours faithfully,
Sina Volz
Dear Ms Volz,
We hereby acknowledge receipt of your e-mail of 19 September 2021
submitted via the AsktheEU.org website, by means of which you requested
access to the “Draft Assessment Reports of Aminopyralid and
Mandipropamid”.
We apologise for the delay in replying to you. Please be informed that
your PAD application has been registered as PAD 2021/129 and is being
processed as quickly as possible in accordance with the provisions of
[1]Regulation (EC) No 1049/2001 on public access to documents
(hereinafter, “the PAD Regulation”).
However, in view of the fact that we are still gathering the elements
relating to the processing of your PAD application, we have to extend the
deadline by 15 working days in accordance with Article 7(3) of the PAD
Regulation. Please accept our apologies for any inconveniences caused by
this delay.
We will reply to you by 3 November 2021 at the latest.
We would like to inform you that the AsktheEU.org website you have used
for submitting your request is a third-party platform, with no link to the
institutions, agencies and bodies of the EU, including EFSA. Consequently,
EFSA cannot be held liable for any errors of any kind occurring as a
result of the use of this platform. Likewise, we would ask you to provide
us with an alternative e-mail address to be used for the further
processing of your application for access to documents.
Additionally, please note that the third party running the AsktheEU.org
website is responsible for the processing of your personal data by means
of this platform. For further information, including the way the third
party addresses your rights in the light of applicable data protection
legislation, please refer to the third party’s privacy policy. From our
experience with the way the platform operates, we understand that the
content of access to documents applicants’ correspondence with EFSA is
usually published on the platform, including any personal data which may
be contained therein (e.g. private postal addresses). Please contact us
directly should you not wish your correspondence with EFSA to be published
on the AsktheEU.org platform. In the event that such a communication is
received from you, EFSA will then redirect all future electronic
correspondence to your private e-mail address only.
Please also be aware that Article 16 of the PAD Regulation regarding
public access to documents provides that this legal framework is
applicable without prejudice to any existing rules on copyright which may
limit a third party's right to reproduce or exploit released documents.
Yours sincerely,
Mariama Mesnaoui
Public Access to documents
Legal and Assurance Services
[2]Description: cid:image001.jpg@01CF4F1E.E87FB350
Via Carlo Magno 1A
IT-43126 Parma
Italy
Tel. +39 0521036264
[3][email address]
[4]www.efsa.europa.eu
[5]twitter.com/EFSA_EU [6]Twitter_logo_blue
[7]youtube.com/EFSAchannel [8]YouTube-logo-full_color
[9]linkedin.com/company/efsa [10][IMG]
This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful. If you are not the intended
recipient, please let the sender know immediately.
Dear Ms Volz,
Please find attached a letter of reply referenced 25413188 from Ms Luisa
Venier for EFSA Public Access to Documents
Yours sincerely,
Mariama Mesnaoui
EFSA Public Access to documents
EFSA Legal and Assurance Services
[1]Description: cid:image001.jpg@01CF4F1E.E87FB350
Via Carlo Magno 1A
IT-43126 Parma
Italy
Tel. +39 0521036264
[2][email address]
[3]www.efsa.europa.eu
[4]twitter.com/EFSA_EU [5]Twitter_logo_blue
[6]youtube.com/EFSAchannel [7]YouTube-logo-full_color
[8]linkedin.com/company/efsa [9][IMG]
This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful. If you are not the intended
recipient, please let the sender know immediately.
From: MESNAOUI Mariama <[email address]> On Behalf Of
EFSA.public.access.to.documents
Sent: Monday 11 October 2021 19:27
To: [FOI #9958 email]
Cc: EFSA.public.access.to.documents
<[email address]>
Subject: PAD 2021/129_Acknowledgement of receipt and extension of the
deadline_Your application for public access to documents (PAD) of 19
September 2021
Dear Ms Volz,
We hereby acknowledge receipt of your e-mail of 19 September 2021
submitted via the AsktheEU.org website, by means of which you requested
access to the “Draft Assessment Reports of Aminopyralid and
Mandipropamid”.
We apologise for the delay in replying to you. Please be informed that
your PAD application has been registered as PAD 2021/129 and is being
processed as quickly as possible in accordance with the provisions of
[10]Regulation (EC) No 1049/2001 on public access to documents
(hereinafter, “the PAD Regulation”).
However, in view of the fact that we are still gathering the elements
relating to the processing of your PAD application, we have to extend the
deadline by 15 working days in accordance with Article 7(3) of the PAD
Regulation. Please accept our apologies for any inconveniences caused by
this delay.
We will reply to you by 3 November 2021 at the latest.
We would like to inform you that the AsktheEU.org website you have used
for submitting your request is a third-party platform, with no link to the
institutions, agencies and bodies of the EU, including EFSA. Consequently,
EFSA cannot be held liable for any errors of any kind occurring as a
result of the use of this platform. Likewise, we would ask you to provide
us with an alternative e-mail address to be used for the further
processing of your application for access to documents.
Additionally, please note that the third party running the AsktheEU.org
website is responsible for the processing of your personal data by means
of this platform. For further information, including the way the third
party addresses your rights in the light of applicable data protection
legislation, please refer to the third party’s privacy policy. From our
experience with the way the platform operates, we understand that the
content of access to documents applicants’ correspondence with EFSA is
usually published on the platform, including any personal data which may
be contained therein (e.g. private postal addresses). Please contact us
directly should you not wish your correspondence with EFSA to be published
on the AsktheEU.org platform. In the event that such a communication is
received from you, EFSA will then redirect all future electronic
correspondence to your private e-mail address only.
Please also be aware that Article 16 of the PAD Regulation regarding
public access to documents provides that this legal framework is
applicable without prejudice to any existing rules on copyright which may
limit a third party's right to reproduce or exploit released documents.
Yours sincerely,
Mariama Mesnaoui
Public Access to documents
Legal and Assurance Services
[11]Description: cid:image001.jpg@01CF4F1E.E87FB350
Via Carlo Magno 1A
IT-43126 Parma
Italy
Tel. +39 0521036264
[12][email address]
[13]www.efsa.europa.eu
[14]twitter.com/EFSA_EU [15]Twitter_logo_blue
[16]youtube.com/EFSAchannel [17]YouTube-logo-full_color
[18]linkedin.com/company/efsa [19][IMG]
This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful. If you are not the intended
recipient, please let the sender know immediately.